Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Privilège Ventures is a Swiss venture capital firm headquartered in Lugano, specializing in seed and early-stage investments across Europe. The firm focuses on three primary sectors: HealthTech, AgriFoodTech, and CleanTech, with a strong emphasis on breakthrough technologies that offer significant social and environmental impact. Privilège Ventures is known for its hands-on, entrepreneurial approach, often leading investment rounds and supporting gender-mixed founding teams. Its life sciences portfolio features companies developing advanced medical imaging, robotic surgery platforms, and non-invasive diagnostics. Authorized by FINMA, the firm leverages the extensive experience of its partners to provide strategic guidance and operational support to its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Privilège Ventures.